Blood clots tied to vaccines can also occur spontaneously, scientists find
The discovery has shed light on a complex blood interaction that has likely always been present in humans but was unnoticed ...
Aplagon secures funding to support Phase IIa trial of APAC therapeutic
Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic ...
Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials
Financing led by new Investors Fåhraeus Startup and Growth and EIC FundHELSINKI, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Aplagon, a ...
jnis.bmj20d
Enhancing thromboresistance of neurovascular nickel-titanium devices with responsive heparin hydrogel coatings
Background Neurointerventional devices, particularly laser-cut thin-strut stents made of self-expanding nickel-titanium alloy, are increasingly utilized for endovascular applications in intracranial ...